Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioCor

1998 FOUNDED
M&A STATUS
81-90 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of clinical data services to the pharmaceutical and biotechnology industries. The company delivers dedicated clinical data services and medical writing capabilities to support the regulatory approval process for new drugs, from initial filing of an investigational new drug (IND) application to the final submission of a new drug application (NDA). It designs clinical studies and protocols, provides biostatistics support, and delivers an array of clinical data management, programming, and medical writing capabilities focused on supporting regulatory submissions in the United States and Europe.

Website
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Medical Records Systems
Acquirer
Primary Office
  • 301 Oxford Valley Road
  • Suite 1725
  • Yardley, PA 19067
  • United States

+1 (215) 000-0000

BioCor Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioCor‘s full profile, request access.

Request full access to PitchBook

BioCor Executive Team (4)

Name Title Board
Seat
Contact
Info
John Oates Chief Financial Officer & Chief Operating Officer
Lukas Makris Ph.D Founder
Andrew Kraus Founder & Vice President
Yota Palli VP, Business Development